Stock Price Quote

AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE1703.05-22.05 (-1.28 %)
PREV CLOSE ( ) 1725.10
OPEN PRICE ( ) 1738.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3034
TODAY'S LOW / HIGH ( )1695.00 1743.65
52 WK LOW / HIGH ( )1283.1 1883
NSE1709.60-15.85 (-0.92 %)
PREV CLOSE( ) 1725.45
OPEN PRICE ( ) 1730.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1709.60 (1560)
VOLUME 114183
TODAY'S LOW / HIGH( ) 1692.55 1745.00
52 WK LOW / HIGH ( )1283.2 1884.55
BSE NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 31-12 1979
Management Info
Mannalal B Agrawal - Chairman Yogesh M Agrawal - Managing Director
Registered Office

Address Ajanta House,Charkop ,Kandivali (W),
Mumbai,
Maharashtra-400067

Phone 91-22-66061000

Email info@ajantapharma.com

Website www.ajantapharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

23Jan Ajanta Pharma informs about board meet
Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has..
26Oct Ajanta Pharma informs about newspaper
Pursuant to Regulation 47 of the Listing Regulations, Ajanta Pharma has..
23Oct Ajanta Pharma informs about board meet
Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has..
10Oct Ajanta Pharma submits disclosures
Ajanta Pharma has submitted Disclosures under Reg. 31(1) and 31(2) of SE..
11Jun Ajanta Pharma informs about disclosure
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
MORE

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit1799.54411.3
Gross Profit 2183.4 6126.7
Operating Profit 2484.67169.8
Net Sales 7331.621964.2
MORE

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE)
peergroup  6383.05 (2.36%)
M.Cap ( in Cr)10595.47
Divis Lab (BSE)
peergroup  3782.95 (1.69%)
M.Cap ( in Cr)100425.44
Dr. Reddys Lab (BSE)
peergroup  4842.45 (1.29%)
M.Cap ( in Cr)80530.54
Pfizer (BSE)
peergroup  5131.65 (1.17%)
M.Cap ( in Cr)23476.13
Cipla (BSE)
peergroup  914.20 (3.28%)
M.Cap ( in Cr)73726.87
MORE

Shareholding Pattern

MUTUAL FUNDS/UTI 9.53%
NON-INSTITUTION 8.67%
PROMOTERS 70.34%
FI/BANKS/INSURANCE 1.35%
GOVERNMENT 0.76%
FII 0%
MORE

Mf Holdings

MORE

About Ajanta Pharma Ltd.

Ajanta Pharma Ltd. was incorporated in the year 1979. Its today's share price is 1703.05. Its current market capitalisation stands at Rs 14736.79 Cr. In the latest quarter, company has reported Gross Sales of Rs. 21964.2 Cr and Total Income of Rs.23806.2 Cr. The company's management includes Gaurang Shah, Anjana Grewal, Prabhakar Dalal, KH Viswanathan, Chandrakant M Khetan, Rajesh M Agrawal, Yogesh M Agrawal, Madhusudan B Agrawal, Mannalal B Agrawal.

It is listed on the BSE with a BSE Code of 532331 , NSE with an NSE Symbol of AJANTPHARM and ISIN of INE031B01049. It's Registered office is at Ajanta House,Charkop ,Kandivali (W)Mumbai-400067, Maharashtra. Their Registrars are ACC Ltd. It's auditors are BSR & Co LLP, Kapoor & Parekh Associates

download beyond app
About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang
Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading
Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays
Derivatives Updates Market Report Overview
IPO IPO Issues Performance News & Analysis
Commodities Market Movers News & Commentary MCX / NCDEX Holidays
Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy
Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research
Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap
Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI ScoresRMS Policy
Connect with Us
ATTENTION INVESTORS Depository IPO KYC
Inactive account treatmentNBSPL Policy of AMLNBEPL Policy of AMLNBCPL Policy of AMLNBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar UpdationNirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019
Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300
For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain.     |    

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

AppleApp Store GooglePlay Store
AppleApp StoreGooglePlay Store
Support
Videos